Example: marketing

K D O Q I C linical P ractice G uideline for N utrition in ...

2/5/09 8:30 AM Page 1. VOL 53, NO 3, SUPPL 2. Supplement to MARCH 2009. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: Vol 53, No 3, Suppl 2, March 2009, Pages S1 S124. 2008 Update Saunders an Imprint of Elsevier Abstract T he 2008 update of the Kidney Disease Outcomes Quality Initiative (KDOQI) pediatric nutrition clinical practice guideline is intended to assist the practitioner caring for infants, children, and adolescents with chronic kidney disease (CKD) stages 2 to 5, on long-term dialysis therapy, or with a kidney transplant. The guideline contains recommendations for evaluation of nutritional status and growth and for counseling and selecting nutrition therapies that are appropriate to age and CKD stage. Therapeutic interventions considered include enteral feeding, intradialytic parenteral nutrition, growth hormone therapy, and restriction or supplementation of various macro- and micronutrients.

Abstract T he 2008 update of the Kidney Disease Outcomes Quality Initiative (KDOQI) pediatric nutrition clinical practice guideline is intended to assist the practitioner caring for infants, children, and adolescents with chronic kidney disease (CKD) stages 2 to 5, on long-term dialysis therapy , or with a

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of K D O Q I C linical P ractice G uideline for N utrition in ...

1 2/5/09 8:30 AM Page 1. VOL 53, NO 3, SUPPL 2. Supplement to MARCH 2009. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: Vol 53, No 3, Suppl 2, March 2009, Pages S1 S124. 2008 Update Saunders an Imprint of Elsevier Abstract T he 2008 update of the Kidney Disease Outcomes Quality Initiative (KDOQI) pediatric nutrition clinical practice guideline is intended to assist the practitioner caring for infants, children, and adolescents with chronic kidney disease (CKD) stages 2 to 5, on long-term dialysis therapy, or with a kidney transplant. The guideline contains recommendations for evaluation of nutritional status and growth and for counseling and selecting nutrition therapies that are appropriate to age and CKD stage. Therapeutic interventions considered include enteral feeding, intradialytic parenteral nutrition, growth hormone therapy, and restriction or supplementation of various macro- and micronutrients.

2 The Work Group drafted narrative reviews based on its expertise and knowledge of the literature in the field and used references to support its write-up. Given the heterogeneity and often unique circumstances of the disease conditions in children with CKD, the Work Group adopted a perspective of issuing recommen- dations of potential use for improving patient survival, health, and quality of life. The recommendations also underwent both internal and external review. Tables of food and formula nutrient content, procedures for anthropometric measurements, copies of growth charts, and a list of resources for calculating energy requirements and anthropometric z scores are provided to assist with implementa- tion. Furthermore, limitations to the recommendations are discussed; comparisons to other guidelines are made; and recommendations are provided for future research.

3 INDEX WORDS: Infants; children and adolescents; chronic kidney disease; dialysis; kidney transplan- tation; nutrition; guideline. American Journal of Kidney Diseases, Vol 53, No 3, Suppl 2 (March), 2009: e1 e1. CONTENTS. VOL 53, NO 3, SUPPL 2, MARCH 2009. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update S1 Tables S2 Figures S3 Abbreviations and Acronyms S5 Glossary of Definitions S6 Reference Key S7 Work Group Membership S8 KDOQI Advisory Board Members S9 Foreword S11 Executive Summary RECOMMENDATIONS. S16 Recommendation 1: Evaluation of Growth and Nutritional Status S27 Recommendation 2: Growth S31 Recommendation 3: Nutritional Management and Counseling S35 Recommendation 4: Energy Requirements and Therapy S48 Recommendation 5: Protein Requirements and Therapy S53 Recommendation 6: Vitamin and Trace Element Requirements and Therapy Continued Contents, Continued S61 Recommendation 7: Bone Mineral and Vitamin D.

4 Requirements and Therapy S70 Recommendation 8: Fluid and Electrolyte Requirements and Therapy S75 Recommendation 9: Carnitine S77 Recommendation 10: Nutritional Management of Transplant Patients APPENDICES. S84 Appendix 1: Procedures for Measuring Growth Parameters S86 Appendix 2: Resources for Calculating Anthropometric SDS/Percentiles, Energy Requirements, and Midparental Height S87 Appendix 3: Nutrient Content Information S91 Appendix 4: Initiating and Advancing Tube Feedings S92 Appendix 5: Clinical Growth Charts S101 Appendix 6: Description of Guideline Development Process WORK GROUP BIOGRAPHIES AND REFERENCES. S105 Biographical and Disclosure Information S108 References NOTICE. SECTION I: USE OF THE CLINICAL PRACTICE GUIDELINE. This Clinical Practice Guideline document is based upon the best information available at the time of publication.

5 It is designed to provide information and assist decision making. It is not intended to define a standard of care and should not be construed as one, nor should it be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or a type of practice. Every health care professional making use of these recommendations is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol. SECTION II: DISCLOSURE. The National Kidney Foundation (NKF) makes every effort to avoid any actual or reasonably perceived conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the Work Group.

6 All members of the Work Group are required to complete, sign, and submit a disclosure and attestation form showing all such relationships that might be perceived or actual conflicts of interest. This document is updated annually and information is adjusted accordingly. All reported information is published in its entirety at the end of this publication in the Work Group members' Biographical and Disclosure Information section and is on file at the NKF. In citing this document, the following format should be used: National Kidney Foundation. KDOQI. Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update. Am J Kidney Dis 53: S1-S124, 2009 (suppl 2). Tables Table 1. Recommended Parameters and Frequency of Nutritional Assessment for Children with CKD Stages 2 to 5 and S16.

7 Table 2. Equations to Estimate Energy Requirements for Children at Healthy S36. Table 3. Equations to Estimate Energy Requirements for Children Ages 3 to 18 Years Who Are S36. Table 4. Physical Activity Coefficients for Determination of Energy Requirements in Children Ages 3 to 18 Years .. S37. Table 5. Nutrient Content or Infusion Rates of IDPN Reported From Small Pediatric Cohorts .. S41. Table 6. Potential Adverse Occurrences with S41. Table 7. Acceptable Macronutrient Distribution Ranges .. S43. Table 8. Additional Recommendations on Specific Types of Fat and Carbohydrate .. S43. Table 9. Dietary Treatment Recommendations for Children with Dyslipidemia and CKD. Stages 5, 5D, and Kidney S44. Table 10. Tips to Implement AHA Pediatric Dietary Guidelines for Prevention or Treatment of Dyslipidemia and CVD in Prepubertal S44.

8 Table 11. Dietary Modifications to Lower Serum Cholesterol and Triglycerides for Adolescents with S45. Table 12. Recommended Dietary Protein Intake in Children with CKD Stages 3 to 5. and 5D .. S49. Table 13. Average Ratio of Phosphorus to Protein Content in Various Protein-Rich Foods .. S51. Table 14. Dietary Reference Intake: Recommended Dietary Allowance and Adequate Intake .. S54. Table 15. Physiological Effects and Sources of Vitamins .. S55. Table 16. Physiological Effects and Sources of Trace S56. Table 17. Dietary Reference Intakes: Tolerable Upper Intake Levels .. S56. Table 18. Multivitamin S57. Table 19. Medicines and Other Substances Interfering with Vitamin B6 and Folic Acid Metabolism That May Contribute to Vitamin Deficiency .. S57. Table 20. Recommended Calcium Intake for Children with CKD Stages 2 to 5 and S61.

9 Table 21. Calcium Content of Common Calcium-Based Binders or Supplements .. S62. Table 22. Recommended Supplementation for Vitamin D Deficiency/Insufficiency in Children with S65. Table 23. Recommended Maximum Oral and/or Enteral Phosphorus Intake for Children with S67. Table 24. Target Range of Serum PTH by Stage of CKD .. S67. Table 25. Age-Specific Normal Ranges of Blood Ionized Calcium, Total Calcium and Phosphorus .. S67. Table 26. DRI for Healthy Children for Water, Sodium, Chloride and S71. Table 27. Insensible Fluid S73. Table 28. Normal Serum Carnitine Levels (!mol/L) .. S75. Table 29. Nutrition-Related Side-Effects of Immunosuppressive Medications .. S78. Table 30. Recommended Frequency of Measurement of Calcium, Phosphorus, PTH and Total CO2 After S81. Table 31. General Food Safety Recommendations for Immunosuppressed S82.

10 Table 32. Resources for Calculating Anthropometric SDS and S86. Table 33. Resources for Calculating Midparental Height .. S86. Table 34. Resources for Calculating Estimated Energy Requirements .. S86. Table 35. Actual and Adjusted Amounts and Ratios of Phosphorus to Protein in Specific Foods .. S87. American Journal of Kidney Diseases, Vol 53, No 3, Suppl 2 (March), 2009: pp S1-S2 S1. S2 Figures Table 36. Nutrient Content of Feeds and Supplements Used in Children with S88. Table 37. Nutrient Content of Selected Foods High in Fiber .. S90. Table 38. Suggested Rates for Initiating and Advancing Tube Feedings .. S91. Table 39. KDIGO Nomenclature and Description for Rating Guideline S102. Table 40. Checklist for Guideline Reporting for the Update of the KDOQI Pediatric Nutrition S102.


Related search queries